The report "Hemostats Market by Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Orthopedic Surgery, General Surgery, Gynecological), Formulation (Sponge, Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2027", size is projected to reach USD 3.7 billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 6.1% during the forecast period. Market is driven by factors such as significant increase in the number of cardiac surgical procedures such as angioplasty and aortic valve replacement and significant capital investments for R&D. Side effects and allergic reactions caused by hemostats is anticipated to restraint the hemostats market growth. Increasing adoption of advanced hemostats in emerging markers will to propel market growth opportunities. However, stringent regulatory framework is anticipated to hinder market development.
Browse 186 market data Tables and 48 Figures spread through 230 Pages and in-depth TOC on "Hemostats Market by Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Orthopedic Surgery, General Surgery, Gynecological), Formulation (Sponge, Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/hemostats-market-9571619.html
Combination Hemostats in product segment to witness the highest growth rate during the forecast period.
Based on the type, the hemostats is classified into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. The thrombin-based hemostats, segment is expected to hold highest share because of its benefits over bovine and human thrombin-based hemostatic agents.
The Matrix & gel hemostats segment of Diagnostic Devices accounted for the largest share of the Hemostats market in 2020
Based on formulation, the hemostats market is segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. In 2020, the matrix & gel hemostats segment accounted for the largest share of the hemostats market. The large share of this segment can be attributed to the advantages associated with these hemostats, such as easy application, biocompatibility, and cost-effectiveness. On the other hand, the sponge hemostats segment is expected to witness the highest growth in the market during the forecast period due to the growing acceptance of these formulations by end users.
Orthopedic surgery application to dominate the hemostats market during the forecast period.
Based on the application, the hemostats is classified into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, reconstructive surgery, and other surgeries. The orthopedics segment is expected to hold highest share because of rising number of sports injuries such as ligament tears and factures.
US dominates the North American Hemostats Market.
Based on the North America region, the Hemostats Market is divided into US and Canada. US is expected to dominate the Hemostats Market. Growing demand for hemostats during surgeries, strong healthcare infrastructure, and growth in the geriatric population are the key factor driving market growth in the US.
The major players in the Hemostats market are C.R. Bard (US), Baxter (US), Teleflex Incorporated (US), Ethicon (Subsidiary of Johnson & Johnson) ( US), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Pfizer (US), etc.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441